Pharmos Corporation

The Iselin, New Jersey firm Pharmos is touting positive data from a proof-of-concept trial of its last remaining pipeline product in the hope of cashing in on the gout goldrush before its own purse is

German firm, vasopharm, said it is seeking a strategic partner to accelerate the further development of VAS203 for traumatic brain injury (TBI), after reporting that Phase IIa results for the drug can

Salix Pharmaceuticals' broad spectrum antibiotic Xifaxan (rifaximin) met its primary endpoint in two Phase III trials, providing symptomatic relief from non-constipation irritable bowel syndrome (IBS)

A court in Brno, in the south-east of the Czech Republic, has upheld a ruling of the country's office for the protection of competition (UOHS) regarding the country's four largest pharmaceutical distr